UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer

Matrix biology, 2017-05, Vol.59, p.3-22

2017

Volltextzugriff (PDF)

Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication

Disease markers, 2015-01, Vol.2015, p.796052-13

2015

Volltextzugriff (PDF)

Multiplex Soluble Biomarker Analysis from Pleural Effusion

Biomolecules (Basel, Switzerland), 2020-07, Vol.10 (8), p.1113

2020

Volltextzugriff (PDF)

The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors

Frontiers in oncology, 2013-01, Vol.3, p.310-310

2013

Volltextzugriff (PDF)

PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations

International journal of molecular sciences, 2022-05, Vol.23 (9), p.4517

2022

Volltextzugriff (PDF)

Utility of BerEp4/calretinin and desmin/epithelial membrane antigen (EMA) dual immunocytochemical staining in effusion cytology

Cancer medicine (Malden, MA), 2023-03, Vol.12 (5), p.5334-5340

2023

Volltextzugriff (PDF)

Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma

Molecular & cellular proteomics, 2014-03, Vol.13 (3), p.701-715

2014

Volltextzugriff (PDF)

Management of cytological material, pre‐analytical procedures and bio‐banking in effusion cytopathology

Cytopathology (Oxford), 2019-01, Vol.30 (1), p.31-38

2019

Volltextzugriff (PDF)

Cytoskeletal Organization Correlates to Motility and Invasiveness of Malignant Mesothelioma Cells

Cancers, 2021-02, Vol.13 (4), p.685

2021

Volltextzugriff (PDF)

Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion

Biomolecules (Basel, Switzerland), 2021-10, Vol.11 (11), p.1606

2021

Volltextzugriff (PDF)

Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma

PloS one, 2013-08, Vol.8 (8), p.e72030-e72030

2013

Volltextzugriff (PDF)

Syndecan-1 Overexpressing Mesothelioma Cells Inhibit Proliferation, Wound Healing, and Tube Formation of Endothelial Cells

Cancers, 2021-02, Vol.13 (4), p.655

2021

Volltextzugriff (PDF)

Heparan Sulfate Proteoglycans May Promote or Inhibit Cancer Progression by Interacting with Integrins and Affecting Cell Migration

BioMed research international, 2015-01, Vol.2015, p.453801-8

2015

Volltextzugriff (PDF)

Nuclear Syndecan-1 Regulates Epithelial-Mesenchymal Plasticity in Tumor Cells

Biology (Basel, Switzerland), 2021-06, Vol.10 (6), p.521

2021

Volltextzugriff (PDF)

Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells

PloS one, 2012-10, Vol.7 (10), p.e48091-e48091

2012

Volltextzugriff (PDF)

Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma

Acta cytologica, 2015-01, Vol.59 (1), p.2-16

2015

Volltextzugriff (PDF)

Mapping the Interactome of the Nuclear Heparan Sulfate Proteoglycan Syndecan-1 in Mesothelioma Cells

Biomolecules (Basel, Switzerland), 2020-07, Vol.10 (7), p.1034

2020

Volltextzugriff (PDF)

Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells

PloS one, 2009-10, Vol.4 (10), p.e7346-e7346

2009

Volltextzugriff (PDF)

Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration

PloS one, 2011-06, Vol.6 (6), p.e14816

2011

Volltextzugriff (PDF)

Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2

PloS one, 2012-06, Vol.7 (6), p.e39474-e39474

2012

Volltextzugriff (PDF)

Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies

BioMed research international, 2014-01, Vol.2014, p.419853-11

2014

Volltextzugriff (PDF)

Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions

Lung cancer (Amsterdam, Netherlands), 2010-04, Vol.68 (1), p.39-43

2010

Volltextzugriff (PDF)

Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma

PloS one, 2012-08, Vol.7 (8), p.e40521-e40521

2012

Volltextzugriff (PDF)

Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics

Biomolecules (Basel, Switzerland), 2021-11, Vol.11 (11), p.1721

2021

Volltextzugriff (PDF)

Comments on the recently published “Guidelines for the cytopathologic diagnosis of epithelioid and mixed‐type malignant mesothelioma”

Cancer cytopathology, 2015-08, Vol.123 (8), p.449-453

2015

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(82)
Buchkapitel
(4)

Sprache

Englisch
(86)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer

Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication

Multiplex Soluble Biomarker Analysis from Pleural Effusion

The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors

PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations

Utility of BerEp4/calretinin and desmin/epithelial membrane antigen (EMA) dual immunocytochemical staining in effusion cytology

Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma

Management of cytological material, pre‐analytical procedures and bio‐banking in effusion cytopathology

Cytoskeletal Organization Correlates to Motility and Invasiveness of Malignant Mesothelioma Cells

Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion

Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma

Syndecan-1 Overexpressing Mesothelioma Cells Inhibit Proliferation, Wound Healing, and Tube Formation of Endothelial Cells

Heparan Sulfate Proteoglycans May Promote or Inhibit Cancer Progression by Interacting with Integrins and Affecting Cell Migration

Nuclear Syndecan-1 Regulates Epithelial-Mesenchymal Plasticity in Tumor Cells

Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells

Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma

Mapping the Interactome of the Nuclear Heparan Sulfate Proteoglycan Syndecan-1 in Mesothelioma Cells

Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells

Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration

Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2

Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies

Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions

Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma

Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics

Comments on the recently published “Guidelines for the cytopathologic diagnosis of epithelioid and mixed‐type malignant mesothelioma”

Suchergebnisse filtern